Stock AKLI AKILI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Akili, Inc.

Equities

AKLI

US00974B1070

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.3925 USD -1.88% Intraday chart for Akili, Inc. +60.20% -19.42%
Apr. 30 Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product CI
Apr. 30 Akili, Inc. to Reduce Workforce CI

Business Summary

Akili, Inc. is a digital medicine company engaged in the development of cognitive treatments through technologies. The Company’s approach of developing and commercializing technologies is designed to directly target the physiology of the brain. Its therapeutic engines are designed to target cognitive functions with the potential to address multiple medical conditions presenting the same functional cognitive impairments. Its product, EndeavorRx, is indicated for use to improve attention function for children ages 8-17 with primarily inattentive or combined-type attention-deficit/hyperactivity disorder (ADHD), who have a demonstrated attention issue. Its product, EndeavorOTC, which is built on the same platform as EndeavorRx, nationwide without a prescription to improve attention function, ADHD symptoms and quality of life in adults 18 years of age and older with primarily inattentive or combined type ADHD. In addition, the Company has several investigator-initiated studies.

Number of employees: 68

Sales per Business

USD in Million2022Weight2023Weight Delta
Digital Medicine Platform
100.0 %
0 100.0 % 2 100.0 % +419.50%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 2 100.0 % +419.50%

Managers

Managers TitleAgeSince
Matthew Franklin CEO
 Chief Executive Officer 50 22-07-31
W. Martucci FOU
 Founder 42 20-11-30
Scott H. Kollins CTO
 Chief Tech/Sci/R&D Officer - 22-11-30
Jonathan David PRN
 Corporate Officer/Principal 46 -
Barrie Brian HRO
 Human Resources Officer - 18-02-28
Jacqueline Studer LAW
 General Counsel 65 22-07-31

Members of the board

Members of the board TitleAgeSince
William Jones BRD
 Director/Board Member 60 22-07-31
Mary Hentges BRD
 Director/Board Member 65 22-10-24
John Spinale BRD
 Director/Board Member 54 Feb. 15
Christine Lemke BRD
 Director/Board Member 47 22-07-31
W. Martucci FOU
 Founder 42 20-11-30
Adam Gazzaley FOU
 Founder 55 20-11-30
Matthew Franklin CEO
 Chief Executive Officer 50 22-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,509,823 60,072,265 ( 76.52 %) 0 76.52 %

Shareholders

NameEquities%Valuation
The Social+Capital Partnership LLC
15.11 %
11,873,000 15.11 % 3 M $
Temasek Holdings Pte Ltd.
14.64 %
11,509,122 14.64 % 3 M $
LB Hercules Holdings LLC
7.350 %
5,776,784 7.350 % 2 M $
Aaron Cowen
5.979 %
4,699,219 5.979 % 1 M $
Baillie Gifford & Co.
5.936 %
4,665,795 5.936 % 1 M $
Suvretta Capital Management LLC
4.888 %
3,841,718 4.888 % 1 M $
Jazz Venture Partners, LLC
4.780 %
3,756,590 4.780 % 1 M $
SHIONOGI & CO., LTD.
2.940 %
2,310,753 2.940 % 670 118 $
Adam Gazzaley
1.386 %
1,089,314 1.386 % 315 901 $
Comprehensive Financial Management LLC (California)
1.353 %
1,063,422 1.353 % 308 392 $

Company contact information

Akili, Inc.

71 Commercial Street

02109, Boston

+

http://www.akiliinteractive.com
address Akili, Inc.(AKLI)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Ratings for Akili, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.4016 USD
Average target price
0.65 USD
Spread / Average Target
+61.85%
Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
AKILI, INC. Stock Akili, Inc.
-19.42% 32.13M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.84% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.35% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.04% 134B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.03% 106B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 61.12B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.89B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.30% 40.3B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.78% 35.53B
RESMED, INC. Stock ResMed, Inc.
+26.14% 32.05B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AKLI Stock
  4. Company Akili, Inc.